Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · April 29, 2023

Analysis of Serious Weight Gain in Patients With ALK-Positive NSCLC Receiving Alectinib

Journal of Thoracic Oncology


Additional Info

Disclosure statements are available on the authors' profiles:

Journal of Thoracic Oncology
Analysis of serious weight gain in patients using alectinib for ALK positive lung cancer
J Thorac Oncol 2023 Mar 29;[EPub Ahead of Print], SP de Leeuw, MA Pruis, BJ Sikkema, M Mohseni, GDM Veerman, MS Paats, DW Dumoulin, EF Smit, AMWJ Schols, RHJ Mathijssen, EFC van Rossum, AC Dingemans

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading